Johnson & Johnson (JNJ)
Sector: | Health Care |
Super Investor Stats: | |
Ownership count: | 12 |
Ownership rank: | 17 |
% of all portfolios: | 0.217% |
Hold Price * : | $157.19 |
Total insider Buys/Sells last 6 months: |
| Transactions | Total |
Buys |
0 |
$0 |
Sells |
2 |
$10,723,734 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
≡ |
Charles Bobrinskoy - Ariel Focus Fund |
3.01 |
|
12,632 |
1,980,000 |
≡ |
Jensen Investment Management |
2.50 |
Reduce 7.65% |
2,105,139 |
329,959,000 |
≡ |
Tweedy Browne Co. - Tweedy Browne Value Fund |
2.28 |
|
63,514 |
10,047,000 |
≡ |
Torray Funds |
2.22 |
Add 13.62% |
87,362 |
13,693,000 |
≡ |
Yacktman Asset Management |
2.21 |
Reduce 0.43% |
1,516,513 |
237,698,000 |
≡ |
Robert Olstein - Olstein Capital Management |
1.55 |
|
60,000 |
9,491,000 |
≡ |
Mairs & Power Growth Fund |
1.49 |
Reduce 7.05% |
513,232 |
81,188,000 |
≡ |
Thomas Gayner - Markel Asset Management |
1.04 |
|
610,800 |
95,736,000 |
≡ |
Prem Watsa - Fairfax Financial Holdings |
0.78 |
|
73,400 |
11,505,000 |
≡ |
Terry Smith - Fundsmith |
0.18 |
Add 1.46% |
278,393 |
43,635,000 |
≡ |
David Katz - Matrix Asset Advisors |
0.06 |
Reduce 1.91% |
3,345 |
529,000 |
≡ |
Lindsell Train |
0.02 |
|
6,065 |
951,000 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock